For the peculiar distribution of specific
mce genes, within group A, the
mce5A,
mce5C, and
mce5E genes were consistently present in almost all strains and potentially played a critical role in the invasion of host cells under hypoxic conditions however further research is needed.
49 All strains across group B displayed the presence of
mce4C and
mce4F genes with multiple pathogenic effects which were well-studied. For encoding a cholesterol transporter,
50,51 mce4 contributes to the entrance of
Nocardia into a tryptophan aspartate-containing coat protein (TACO) – coated phagosomes to prevent the degradation of lysosomes,
52 meanwhile promoting the localization and invasion of
Nocardia to host cells through cholesterol-rich domains of the plasma membrane.
53,54 Furthermore,
mce4C and
mce4F genes allow
Nocardia to grow under hypoxic conditions, by taking in cholesterol as a carbon source, therefore, providing energy for
Nocardia survival inside the cornea and deeper invasion.
48 All strains in group C contained the
mce4F gene, thus obtaining similar basic pathogenic properties to group B.
Mce4F, an essential component of the
mce4 operon, is found in the genomes of mycobacteria and
Nocardia.
55 Mce4F encodes external membrane proteins, crucial for bacterial pathogenesis.
56 This study indicates the highly conservation of
mce4F across various
Nocardia strains, making it a valuable and reliable diagnostic marker, especially for early detection, saving time compared to the culture method. Additionally, Kendall et al.
57 demonstrated that the KstR|Rv3574 transcriptional regulon controls
mce4F expression through lipid catabolism, vital for bacterial survival. Therefore,
mce4F shows promise as a potential therapeutic target for combating these infections. Remarkably, the
mce3C gene was only detected in the strains of
Nocardia in group C, which triggered the immune escape by promoting
Nocardia to invade and survive within macrophages and other inflammatory cells.
47,58 The ubiquitous presence of
mce3C within group C might be the cause of poor clinical manifestations and outcomes of the patients and also can be the biomarker to evaluate the prognosis of
Nocardia keratitis, especially in the early stage of the disease.